Get the app
US › Healthcare

XBiotech Inc (XBIT)

US · Healthcare · Biotechnology

$1.89+1.07%
Last close · 2026-11-06

Latest quarter · ended 2026-06-30

Revenue
$0
Net profit
$-6.7M
EPS
$-0.22

Key statistics

Market cap
$57.0M
Forward P/E
0.0
P/B
0.45
Book value
$4.21
EPS (TTM)
$-1.48
52-week high
$3.44
52-week low
$1.80
50-day MA
$2.12
200-day MA
$2.31
Beta
0.74

Analyst view

with an average price target of $18.00.

Shareholding

Insiders
38.08%
Institutions
6.73%

Largest institutional holders

FundStake
BlackRock Inc1.05%
Geode Capital Management, LLC0.70%
Vanguard Capital Management, LLC0.66%
RBF LLC0.65%
Morgan Stanley - Brokerage Accounts0.48%
Bridgeway Capital Management, LLC0.32%
Vanguard Fiduciary Trust Co0.30%
Millennium Management LLC0.26%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for XBiotech Inc — free to start.

Open in the appGoogle PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncMerck & Company IncUnitedHealth Group IncorporatedNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncAmgen IncGilead Sciences IncAbbott LaboratoriesNovo Nordisk A/S

Data updated 2026-11-07.